Log In
BCIQ
Print this Print this
 

vericiguat (BAY 1021189, BAY102, MK-1242)

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionSoluble guanylate cyclase (sGC) stimulator
Molecular Target Soluble guanylate cyclase (sGC)
Mechanism of ActionGuanylate cyclase activator
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationHeart failure
Indication DetailsTreat chronic heart failure (CHF)
Regulatory Designation
PartnerMerck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$2,100.0M

$1,000.0M

$1,100.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/12/2014

$2,100.0M

$1,000.0M

$1,100.0M

Get a free BioCentury trial today